Treatment of ADHD with Comorbid Depression

Introduction to Combination Therapy

The American Academy of Child and Adolescent Psychiatry recommends initiating treatment with methylphenidate as the first line, given that stimulants have response rates of 70-80% and can resolve comorbid depressive or anxious symptoms in many cases 1, 2
Response to stimulants can be evaluated within days, allowing for rapid assessment of efficacy 2
If ADHD symptoms improve but depressive symptoms persist, adding sertralina to the stimulant regimen is recommended 2
For patients with severe depression, addressing the mood disorder first with sertralina, then adding methylphenidate for persistent ADHD symptoms, is advised 2

The therapeutic range for sertralina is 50-200mg/day, with 200mg being the maximum FDA-approved dose 3
Dose changes should not occur at intervals less than 1 week due to the elimination half-life of 24 hours 3
Higher doses of SSRIs are associated with more adverse effects without clear evidence of greater efficacy 3
Methylphenidate dosing for adults is 5-20mg three times a day, with prolonged-release formulations providing all-day effects and reducing rebound symptoms 2
Titration should be systematic until optimal effect, prioritizing clinical judgment over strict mg/kg calculations 2

Monitoring for serotonin syndrome, a potentially life-threatening condition, is crucial, especially during initiation and dose adjustments of sertralina and methylphenidate 3, 4
Blood pressure and pulse should be monitored at the start and regularly during treatment, as both medications can increase heart rate and blood pressure 4, 2
Avoid stimulants in patients with uncontrolled hypertension or symptomatic cardiovascular disease 2
Regular evaluation for suicidal ideation, behavioral activation, and clinical worsening, especially during the first weeks of treatment, is necessary 4

With methylphenidate, common adverse effects include loss of appetite and weight, sleep disturbances, irritability, and headache 1, 5
Management strategies for specific adverse effects, such as adjusting dosing for sleep disturbances or using high-calorie snacks for appetite loss, can be effective 5

In patients with a history of substance abuse, considering formulations of stimulants with lower abuse potential, like Concerta, or using atomoxetine as a first-line treatment due to its non-controlled substance status, is recommended 5, 2
Implementing urine drug screening to ensure compliance and detect any return to substance use is advised 2
During pregnancy, bupropion may be considered as an alternative to stimulants, although it is associated with a small increased risk of certain cardiovascular malformations in first-trimester exposure 2

Pharmacological treatment should be part of a comprehensive approach including psychoeducation and psychosocial/psychotherapeutic interventions 2
Cognitive-behavioral therapy (CBT) specifically developed for ADHD is the most studied and effective psychotherapy for treating ADHD and depression in adults, with greater effectiveness when combined with medication 2
Combined therapy (stimulant plus behavioral therapy) offers superior outcomes when ADHD coexists with mood disorders 2